Intravesikale Instillationstherapie beim oberflächlichen Harnblasenkarzinom, Leitlinien und Wirklichkeit: Versorgungsstudie

Background: The aim of this questionnaire was to obtain an impression of the practice and applied therapeutic agents in postoperative and adjuvant intravesical therapy of superficial bladder tumours. Patients and Methods: Standardised questionnaires answered by urologists about instillation therapy in 351 patients were analysed. Results: Results showed a discrepancy between the clinical practice and the guidelines in respect of the postoperative instillations and the use of BCG immunotherapy, respectively. Conclusion: It does not seem to be standard practice to treat every patient with one immediate post-operative instillation. Only a minority of high-risk patients received intravesical BCG instillations. Substances mainly used for instillation therapy were mitomycin C and doxorubicin.